Investigator
Fox Chase Cancer Center
Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma
Kinome profiling of ovarian tumors reveals a way to treat patients and get a step ahead of drug resistance.
